Loading…
This event has ended. Visit the official site or create your own event on Sched.
THE BIG FESTIVAL ABOUT SMALL CITIES
Tom Tom champions civic innovation, creativity, and entrepreneurship in America’s hometowns.

[Back to Tom Tom Festival]
Back To Schedule
Friday, April 12 • 2:30pm - 3:15pm
Do No Harm: Building Health Tech Companies to Help People

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
Mylea Charvat, Ph.D., is a clinical psychologist, translational neuroscientist, and the CEO and founder of the digital cognitive assessment company, Savonix. Dr. Charvat founded Savonix in 2015 to address a critical challenge in the healthcare world: how do we assess the mental health, specifically the cognitive and emotional function, of patients on a large scale despite limited dollars and insufficient numbers of trained specialists? 

A trained clinical psychologist with a neuro specialty, Dr. Charvat is a recognized thought leader in her field. She completed her fellowship in clinical neuroscience at Stanford School of Medicine and has been a lecturer at Stanford, the University of San Francisco and San Francisco State University. She has authored several peer-reviewed articles published in well-respected mental health and neuro-imaging journals. She is a frequent guest author for the Huffington Post, has written for Tech Crunch and has appeared as a subject matter expert at multiple conference and events including with The Atlantic Council, Hyper Wellbeing, and The CA State Forensic Medical Association. 

Hear her founding story and what it takes to stay grounded while running a biotech company.


You need this ticket from Eventbrite to sign up: Entrepreneurial Ecosystems Conference.

Speakers
avatar for Mylea Charvat

Mylea Charvat

CEO, Savonix
Dr. Mylea Charvat, a clinical psychologist and translational neuroscientist founded Savonix to address a critical challenge in the health care world – how do we assess the cognitive function of patients on a large scale despite limited dollars and insufficient numbers of specialists.Mylea... Read More →

Sponsors